Related Experiment Video
Updated: Aug 22, 2026

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
Published on: December 5, 2025
Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis
Caroline Davison1, Kathleen M Ventre, Marco Luchetti
1Department of Anaesthesia, St. George's Hospital, Tooting, London, UK.
Insights
No current treatments clearly improve outcomes for infants with severe bronchiolitis. Surfactant shows promise, while corticosteroids and ribavirin may offer benefits for respiratory support.
Area of Science:
- Pediatrics
- Critical Care Medicine
- Respiratory Medicine
Background:
- Viral bronchiolitis is a primary cause of respiratory failure in infants.
- Current treatments primarily focus on supportive care.
- Evidence for interventions in mechanically ventilated infants is limited.
Purpose of the Study:
- To assess the evidence supporting treatments for critically ill infants with bronchiolitis.
- To evaluate the effectiveness of available therapies.
Main Methods:
- Systematic search of medical literature (PubMed, citations, expert contact).
- Inclusion of randomized controlled trials (RCTs) involving infants in intensive care units.
- Independent data extraction and quality assessment by two reviewers.
Main Results:
- 16 RCTs were included from 2,319 screened citations.
- Meta-analysis of surfactant studies indicated a trend toward reduced mechanical ventilation duration and significant reduction in ICU days.
- Meta-analysis of systemic corticosteroid studies showed no significant effect on ventilation duration.
Conclusions:
- No definitive effective interventions currently exist for critically ill infants with bronchiolitis.
- Surfactant therapy appears promising for improving outcomes.
- Corticosteroids and ribavirin may offer potential benefits.
Background:
Viral bronchiolitis is the leading cause of respiratory failure among infants in the United States. Currently, the mainstay of treatment is supportive care. The effectiveness of treatments used for mechanically ventilated infants with bronchiolitis is unclear.
Objective:
To evaluate the strength of the evidence supporting the use of currently available treatments for critically ill infants with bronchiolitis.
Data Source:
We searched PubMed, citations of relevant articles, personal files, and conference proceedings, and we contacted experts in the field.
Study Selection:
Randomized, controlled trials evaluating any therapy for bronchiolitis that included children in an intensive care unit.
Data Extraction:
Two reviewers independently extracted data and assessed methodologic quality.
Data Synthesis:
A total of 2,319 citations were screened, and 16 randomized, controlled trials were included. There were three trials of surfactant, three of ribavirin, three of immune globulin, three of systemic corticosteroids, and one each of vitamin A, interferon, erythropoietin, and heliox. A meta-analysis of the three surfactant studies showed a strong trend toward a decrease in duration of mechanical ventilation of 2.58 days (95% confidence interval, -5.34 to 0.18 days; p =.07) and a significant decrease of 3.3 intensive care unit days (95% confidence interval, -6.38 to -0.23 days; p =.04). A meta-analysis of the three systemic corticosteroid studies showed no overall effect on duration of mechanical ventilation when all three trials were combined (-0.62 day; 95% confidence interval, -2.78 to 1.53 days; p =.57). We identified one published meta-analysis of three ribavirin studies showing a significant decrease in ventilator days with ribavirin (-1.2 days; 95% confidence interval, -0.2 to -3.4 days; p =.2).
Conclusions:
Currently, there are no clearly effective interventions available to improve the outcome of critically ill infants with bronchiolitis. Surfactant seems to be a promising intervention, and corticosteroids or ribavirin may also be beneficial.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Respiratory Syncytial Virus Disease
COPD: Management Using Bronchodilators and Corticosteroids
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Pulmonary Cycle: Exhalation